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Implications of Using the ND1 Gene as a Control Region for
Real-Time PCR Analysis of Mitochondrial DNA Deletions
in Human Skin
To the Editor:
Previous work by our group and others has demonstrated
that mitochondrial DNA (mtDNA) deletions may be useful as
a biomarker of cumulative ultraviolet radiation exposure in
human skin (Birch-Machin, 2000). Of particular importance
is the incidence of various mtDNA deletions, including the
4977 bp ‘‘common’’ deletion, which has been strongly associ-
ated with increased sun exposure in human skin (Birch-
Machin et al, 1998; Ray et al, 2000) and UV irradiation in
cultured skin cells (Berneburg et al, 1999). Until recently, a
rapid reliable technique has not been available for quantifying
low levels (i.e., o1%) of these mitochondrial deletions
(Krishnan et al, 2003). For this reason, researchers have
begun to look towards real-time PCR assays to provide
reliable quantification of low levels of deletions. To date, the
only published real-time PCR assay for a single deletion is that
for the ‘‘common’’ deletion (Koch et al, 2001). The incidence
of the common deletion, however, is likely to be only the tip of
the deletion iceberg (Ray et al, 2000), and so the spectrum of
the many other mtDNA deletions has been investigated in
sun-exposed skin and skin cancer (Ray et al, 2000; Durham et
al, 2003). These latter studies have been limited however due
to the qualitative nature of the methodology.
Recently, a real-time Taqman PCR assay has been
described, which attempts to solve this problem by claiming
to quantify the level of the mtDNA deletion spectrum in
muscle cells (He et al, 2002). The assay uses two probe
regions in the mitochondrial genome, firstly the control
probe region in the ND1 gene, and secondly the test probe
region in the ND4 gene (Fig 1). The ND1 gene lies in the part
of the genome that has been historically called the minor
deletion arc, because it is thought to have very few
deletions (Mitomap, 2001). This has prompted its use as
the control region in the assay. In contrast, the ND4 probe
resides in the major deletion arc, an area that has been
frequently reported to contain many deletions (Mitomap,
2001). In order to estimate the level of total major arc
deletions within a sample, the assay calculates the ratio of
the copy number of the ND1 probe to the ND4 probe.
Using a qualitative long extension PCR technique,
we have previously described a spectrum of large-scale
mtDNA deletions in non-melanoma skin cancer (NMSC)
samples and their histologically normal perilesional skin
(Durham et al, 2003). This study addresses the question of
whether the real-time PCR deletion assay described by He
et al (2002) is able to provide a robust and reliable means of
quantifying the deletion spectrum that has been identified in
these NMSC and perilesional skin samples.
Analysis of large-scale mtDNA deletions Large-scale
mtDNA deletions were analyzed in tumor samples and the
histologically normal perilesional dermis and epidermis from
each NMSC patient. Within each sample, the ratio of
deleted:wild-type mtDNA deletions in the major deletion arc
was determined by the real-time PCR assay of He et al
(2002) (Table I). The total number of deletions was estimated
by long extension PCR amplification of the whole mito-
chondrial genome in two regions representing the major and
minor deletion arcs (Table I). In addition, high levels (i.e.,41%)
of the common deletion were quantified by a radioactive
3-primer PCR assay (Table I). As expected, the levels of
deletions estimated using the real-time PCR assay generally
reflected the pattern of deletions observed with the long
extension PCR and the 3-primer PCR assays. Importantly,
however, in a number of samples (i.e., five of 30, highlighted
as shaded columns in Table I), the levels of deletions deter-
mined by real-time PCR were clearly lower than might be
expected from the long extension PCR assay and the
3-primer PCR common deletion results. A detailed analysis
of the results from these five samples showed that all har-
bored a specific deletion of approximately 4 kb in size as
determined by the long extension PCR assay of the minor
deletion arc (Table I, denoted by þ ). For example, in Patient
3, the level of total major arc deletions as determined by
real-time PCR in the dermis was almost identical to the level
found in the tumor from the same patient (10.7 vs 10.1,
respectively), despite the dermis having a far greater number
of deletions in the long extension PCR assay of the major
deletion arc (i.e., 9 vs 1) and 6.8% common deletion compared
to undetectable in the tumor (3-primer PCR) (Table I).
Identiﬁcation of the 3895 bp deletion identiﬁed by the
long extension PCR assay As these five patient samples
all harbored an unidentified minor arc deletion of approxi-
mately 4 kb in size, a literature search on previously reported
mtDNA deletions was performed. This search revealed a
candidate deletion of 3895 bp in size, which had only been
previously reported in diseased muscle (Moraes et al, 1992).
To confirm the presence of this candidate deletion in our
patient samples, PCR primers were designed that flanked
the deletion break points. These formed the basis of a
Abbreviations: MtDNA, Mitochondrial DNA; NMSC, non-melanoma
skin cancer
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sensitive 3895 bp deletion-specific PCR assay, which was
then performed on our NMSC and corresponding perile-
sional skin samples. The results showed that all the samples
that had previously exhibited the  4 kb minor arc deletion
band identified by long extension PCR also produced a
strong PCR product of the expected size. Automated
sequencing of the cloned PCR product confirmed the
identity of the deletion to be the 3895 bp deletion previously
reported only in muscle (Moraes et al, 1992).
The breakpoints of the 3895 bp deletion are at nucleotide
positions 548 and 4442 (Fig 1). The deletion region encom-
passes, part of the non-coding D-loop, the entire 12S rRNA,
16S rRNA and ND1 genes and part of the ND2 gene (Fig 1).
Of critical importance is that the deletion removes the ND1
region used for the control probe in the real-time PCR assay
for quantification of mitochondrial deletions in the major
deletion arc. The effect on the real-time PCR assay is to
lower the control region copy number as detected by the
assay. This will in turn alter the ratio between the ND1
control probe and the ND4 test probe data thereby lowering
the perceived level of deletions in the major arc. This
explains the apparent anomalies in the results from the
five samples detailed in Table I (shaded columns). More
importantly, it highlights the danger of using this ND1 region
in the quantification of total mitochondrial DNA deletions by
this particular real-time PCR assay in human skin.
Incidence of the 3895 bp deletion in human NMSC and
blood As the 3895 bp deletion PCR assay is more sensitive
and specific than the long extension PCR assay of the minor
arc, it was used to detect low levels of the deletion in NMSC
and the corresponding perilesional skin. The results showed
that the deletion was observed in 73% of samples (n¼ 30).
The pattern of expression of the deletion appeared to
depend on the type of tumor, with the deletion being found
in three of the five basal cell carcinoma (BCC) tumors,
whereas in the squamous cell carcinoma (SCC) patients, the
deletion was observed in the perilesional dermis rather than
the tumor itself. Figure 2 shows a typical example of the 3895
bp deletion PCR results for BCC, SCC, and their corre-
sponding perilesional dermis and epidermis. In confirmation
of our earlier results, those samples which had the strongest
PCR products were the shaded samples in Table I where the
level of deletion determined by the real-time PCR assay were
much lower than one would have expected based on the
long extension PCR and 3-primer common deletion data.
In mitochondrial diseases involving mtDNA deletions,
the incidence of the deletion is normally absent or barely
detectable in the corresponding blood of the patient
(Berneburg et al, 1997). In accordance with this situation,
we did not find the 3895 bp mtDNA deletion in 12 blood
samples that were investigated (the results from two
samples are shown in Fig 2).
In summary, we have shown the presence of a rarely
reported minor arc 3895 bp mtDNA deletion in 73% of
tumor and corresponding histologically normal perilesional
skin samples (n¼30). As these samples are taken from
constant sun-exposed body sites (i.e., face), it is currently
unknown whether the incidence of the 3895 bp deletion is
associated with the degree of sun-exposure. Importantly,
this deletion removes the ND1 region of the mitochondrial
genome. We have provided clear evidence to show that this
severely limits the usefulness of those real-time assays,
which use the ND1 region for the control probe in the
quantification of the mtDNA deletion spectrum particularly
in human skin.
Figure 1
Mitochondrial genome map. Diagram of the
mitochondrial genome showing the location of
the ND1 (minor deletion arc) and ND4 (major
deletion arc) probes used in the real-time PCR
assay described by He et al (2002). The region
encompassed by the 3895 bp deletion is also
highlighted.
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Figure 2
Incidence of the 3895 bp deletion in NMSC and blood. The 3895 bp
deletion PCR was carried out in a 25 mL reaction containing  200 ng
genomic DNA, 600 nM of each primer, 250 mM dNTPs, 0.6 U per
reaction Amplitaq Gold DNA polymerase (Applied Biosystems),
GeneAmp buffer (containing, 100 mM Tris–HCl, pH 8.3, 500 mM KCl,
15 mM MgCl and 0.01% (wt/vol) gelatin). The PCR primers used were
L404 (50CTT TTG GCG GTA TGC ACT TT 30) (404–423nt) and H4676
(50GAT TAT GGA TGC GGT TGC TT 30) (4657–4676nt). Primers L404 and
H4676 were designed to anneal outside the 3895 bp deletion. During
DNA amplification the polymerase extension time was designed to be
too short for amplification of wild-type PCR products allowing only
amplification of the shorter deleted mtDNA fragment. The PCR
conditions were 941C for 10 min, 35 cycles of 941C for 30 s, 561C for
30 s, 721C for 30 s and a final extension of 7 min at 721C. This ethidium
bromide stained 1% agarose gel shows a typical example of the 3895
bp deletion PCR results for the NMSCs, their corresponding perile-
sional dermis and epidermis and blood. Lanes 1 and 11¼molecular
weight markers (Hyperladder IV, range 1000–100 bp, Bioline Ltd,
London, UK); lanes 2–4¼ tumor, dermis, and epidermis of a BCC
patient; lanes 5–7¼ tumor, dermis, epidermis of a SCC patient; lanes 8
and 9¼blood; lane 10¼no DNA control.
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